Chaiwiriyawong, S.; Assawasuwannakit, S.; Feuangwattana, P.; Sripongpun, P.; Chamroonkul, N.; Piratvisuth, T.; Kaewdech, A.
Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B. Diagnostics 2024, 14, 1325.
https://doi.org/10.3390/diagnostics14131325
AMA Style
Chaiwiriyawong S, Assawasuwannakit S, Feuangwattana P, Sripongpun P, Chamroonkul N, Piratvisuth T, Kaewdech A.
Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B. Diagnostics. 2024; 14(13):1325.
https://doi.org/10.3390/diagnostics14131325
Chicago/Turabian Style
Chaiwiriyawong, Supakorn, Suraphon Assawasuwannakit, Poorikorn Feuangwattana, Pimsiri Sripongpun, Naichaya Chamroonkul, Teerha Piratvisuth, and Apichat Kaewdech.
2024. "Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B" Diagnostics 14, no. 13: 1325.
https://doi.org/10.3390/diagnostics14131325
APA Style
Chaiwiriyawong, S., Assawasuwannakit, S., Feuangwattana, P., Sripongpun, P., Chamroonkul, N., Piratvisuth, T., & Kaewdech, A.
(2024). Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B. Diagnostics, 14(13), 1325.
https://doi.org/10.3390/diagnostics14131325
